{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:41:24Z","timestamp":1740170484241,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T00:00:00Z","timestamp":1489190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["VEGA 1\/0112\/17"],"award-info":[{"award-number":["VEGA 1\/0112\/17"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40520-017-0745-4","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T20:11:50Z","timestamp":1489176710000},"page":"1121-1127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Non-persistence with antiplatelet therapy in elderly patients after a transient ischemic attack"],"prefix":"10.1007","volume":"29","author":[{"given":"Martin","family":"Wawruch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dusan","family":"Zatko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Gejza","family":"Wimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Luha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sona","family":"Wimmerova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kukumberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Murin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Hloska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,11]]},"reference":[{"key":"745_CR1","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"JD Easton","year":"2009","unstructured":"Easton JD, Saver JL, Albers GW et al (2009) Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 40:2276\u20132293","journal-title":"Stroke"},{"key":"745_CR2","first-page":"1","volume":"15","author":"S Sehatzadeh","year":"2015","unstructured":"Sehatzadeh S (2015) Is transient ischemic attack a medical emergency? An evidence-based analysis. Ont Health Technol Assess Ser 15:1\u201345","journal-title":"Ont Health Technol Assess Ser"},{"key":"745_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/jnnp.74.5.577","volume":"74","author":"TG Clark","year":"2003","unstructured":"Clark TG, Murphy MF, Rothwell PM (2003) Long term risks of stroke, myocardial infarction, and vascular death in \u201clow risk\u201d patients with a non-recent transient ischaemic attack. J Neurol Neurosurg Psychiatry 74:577\u2013580","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"745_CR4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","volume":"6","author":"MF Giles","year":"2007","unstructured":"Giles MF, Rothwell PM (2007) Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 6:1063\u20131072","journal-title":"Lancet Neurol"},{"key":"745_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","volume":"383","author":"VL Feigin","year":"2014","unstructured":"Feigin VL, Forouzanfar MH, Krishnamurthi R et al (2014) Global and regional burden of stroke during 1990\u20132010: findings from the Global Burden of Disease Study 2010. Lancet 383:245\u2013254","journal-title":"Lancet"},{"key":"745_CR6","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR et al (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 45:2160\u20132236","journal-title":"Stroke"},{"key":"745_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","volume":"376","author":"MJ O\u2019Donnell","year":"2010","unstructured":"O\u2019Donnell MJ, Xavier D, Liu L et al (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376:112\u2013123","journal-title":"Lancet"},{"key":"745_CR8","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s00228-007-0340-2","volume":"63","author":"J Hasford","year":"2007","unstructured":"Hasford J, Schr\u00f6der-Bernhardi D et al (2007) Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study. Eur J Clin Pharmacol 63:1055\u20131061","journal-title":"Eur J Clin Pharmacol"},{"key":"745_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA et al (2012) A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73:691\u2013705","journal-title":"Br J Clin Pharmacol"},{"key":"745_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s40520-015-0435-z","volume":"28","author":"A Giardini","year":"2016","unstructured":"Giardini A, Martin MT, Cahir C et al (2016) Toward appropriate criteria in medication adherence assessment in older persons: Position Paper. Aging Clin Exp Res 28:371\u2013381","journal-title":"Aging Clin Exp Res"},{"key":"745_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s40520-015-0516-z","volume":"28","author":"Y Hou","year":"2016","unstructured":"Hou Y, Zhang D, Gu J et al (2016) The association between self-perceptions of aging and antihypertensive medication adherence in older Chinese adults. Aging Clin Exp Res 28:1113\u20131120","journal-title":"Aging Clin Exp Res"},{"key":"745_CR12","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1212\/WNL.0b013e31822f0423","volume":"77","author":"CD Bushnell","year":"2011","unstructured":"Bushnell CD, Olson DM, Zhao X et al (2011) Secondary preventive medication persistence and adherence 1\u00a0year after stroke. Neurology 77:1182\u20131190","journal-title":"Neurology"},{"key":"745_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/STROKEAHA.109.566950","volume":"41","author":"EL Glader","year":"2010","unstructured":"Glader EL, Sj\u00f6lander M, Eriksson M et al (2010) Persistent use of secondary preventive drugs declines rapidly during the first 2\u00a0years after stroke. Stroke 41:397\u2013401","journal-title":"Stroke"},{"key":"745_CR14","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00228-012-1293-7","volume":"68","author":"K \u00d8stergaard","year":"2012","unstructured":"\u00d8stergaard K, Hallas J, Bak S et al (2012) Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data. Eur J Clin Pharmacol 68:1631\u20131637","journal-title":"Eur J Clin Pharmacol"},{"key":"745_CR15","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1093\/eurheartj\/eht356","volume":"34","author":"M Nichols","year":"2013","unstructured":"Nichols M, Townsend N, Scarborough P et al (2013) Cardiovascular disease in Europe: epidemiological update. Eur Heart J 34:3028\u20133034","journal-title":"Eur Heart J"},{"key":"745_CR16","unstructured":"Health Statistics Yearbook of the Slovak Republic (2014) \n                    http:\/\/www.nczisk.sk\/Documents\/rocenky\/2014\/rocenka_2014.pdf\n                    \n                  . Accessed 12 Dec 2016"},{"key":"745_CR17","volume-title":"10th Revision","author":"ICD\u201410th International Statistical Classification of Diseases and Related Health Problems","year":"1992","unstructured":"ICD\u201410th International Statistical Classification of Diseases and Related Health Problems (1992) 10th Revision. WHO, Geneva"},{"key":"745_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ageing\/9.2.73","volume":"9","author":"J Williamson","year":"1980","unstructured":"Williamson J, Chopin JM (1980) Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing 9:73\u201380","journal-title":"Age Ageing"},{"key":"745_CR19","unstructured":"Guidelines for ATC classification and DDD assignment (2016) WHO Collaborating Centre for drug statistics methodology. Oslo"},{"key":"745_CR20","volume-title":"Biostatistical methods in epidemiology","author":"SC Newman","year":"2001","unstructured":"Newman SC (2001) Biostatistical methods in epidemiology. Wiley, Chichester"},{"key":"745_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1185\/03007991003670563","volume":"26","author":"JP Burke","year":"2010","unstructured":"Burke JP, Sander S, Shah H et al (2010) Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors. Curr Med Res Opin 26:1023\u20131030","journal-title":"Curr Med Res Opin"},{"key":"745_CR22","first-page":"313","volume":"12","author":"FT Shaya","year":"2006","unstructured":"Shaya FT, El Khoury AC, Mullins CD et al (2006) Drug therapy persistence and stroke recurrence. Am J Manag Care 12:313\u2013319","journal-title":"Am J Manag Care"},{"key":"745_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00228-013-1609-2","volume":"70","author":"K \u00d8stergaard","year":"2014","unstructured":"\u00d8stergaard K, Madsen C, Liu ML et al (2014) Long-term use of antiplatelet drugs by patients with transient ischaemic attack. Eur J Clin Pharmacol 70:241\u2013248","journal-title":"Eur J Clin Pharmacol"},{"key":"745_CR24","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1001\/archinte.164.21.2343","volume":"164","author":"RW Grant","year":"2004","unstructured":"Grant RW, O\u2019Leary KM, Weilburg JB et al (2004) Impact of concurrent medication use on statin adherence and refill persistence. Arch Intern Med 164:2343\u20132348","journal-title":"Arch Intern Med"},{"key":"745_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1179\/1743132812Y.0000000107","volume":"35","author":"R Ji","year":"2013","unstructured":"Ji R, Liu G, Shen H et al (2013) Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry. Neurol Res 35:29\u201336","journal-title":"Neurol Res"},{"key":"745_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00228-015-1996-7","volume":"72","author":"A Citarella","year":"2016","unstructured":"Citarella A, Linder M, Kieler H et al (2016) Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence. Eur J Clin Pharmacol 72:349\u2013357","journal-title":"Eur J Clin Pharmacol"},{"key":"745_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s40266-016-0365-2","volume":"33","author":"M Wawruch","year":"2016","unstructured":"Wawruch M, Zatko D, Wimmer G Jr et al (2016) Factors influencing non-persistence with antiplatelet medications in elderly patients after ischaemic stroke. Drugs Aging 33:365\u2013373","journal-title":"Drugs Aging"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40520-017-0745-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-017-0745-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-017-0745-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T15:18:15Z","timestamp":1581952695000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40520-017-0745-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1007\/s40520-017-0745-4","relation":{},"ISSN":["1720-8319"],"issn-type":[{"type":"electronic","value":"1720-8319"}],"subject":[],"published":{"date-parts":[[2017,3,11]]},"assertion":[{"value":"20 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was supported by a grant of the Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic VEGA 1\/0112\/17. The providers of this grant played no role in study design, methodology, data collection, analysis and interpretation of the data, preparation of the paper, or in the decision to submit the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Under the applicable legal principles of our country, there was no requirement to seek approval of an Ethical Committee. The human rights and rules of personal data confidentiality were fully respected.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}